Clinical Trials · NCT06069622
Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment
- Phase
- N/A
- Recruitment status
- Recruiting
- Sponsor
- Brigham and Women's Hospital
- Enrollment
- 30
- Start date
- Nov 2023
- Locations
- 1 site, United States
- Primary endpoint
- Blood pressure response to GLP-1 RA treatment